Bookmark
Forward
In brief: Edaravone oral suspension (Radicava ORS) for ALS.
The Medical letter on drugs and therapeutics 2022 Sep 05Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
In brief: Edaravone oral suspension (Radicava ORS) for ALS. The Medical letter on drugs and therapeutics. 2022 Sep 05;64(1658):e1
Mesh Tags
Substances
PMID: 36098666
View Full Text
